SEC Form 4
Intuitive Surgical Inc. (ISRG) insider trading
In the 12 months to Oct 24, 2026, 12 ISRG insiders reported open-market sales of $91.0M across 45 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $91.0M
- 45 filings · 12 insiders
- Open-market purchases
- $0
- 0 filings
- Pre-arranged sales (10b5-1)
- 45 of 45
- All $91.0M sold was pre-arranged
Who traded ISRG, and when
- Sale
- Sale, pre-arranged (10b5-1)
ISRG daily close from Oct 24, 2025 to Oct 23, 2026, between $332.02 and $592.85, last $452.29. 45 sale and 0 purchase filings by 12 insiders, marked at their filing dates. Gary S. Guthart, Executive Chair of the Board o → Director: sold $48.8M across 4 filings, first filed Oct 27, 2025, last Aug 12, 2026. David J. Rosa, Chief Executive Officer (CEO): sold $13.4M across 1 filing, first filed Oct 27, 2025, last Oct 27, 2025. Myriam Curet, EVP & Chief Medical Officer: sold $8.4M across 10 filings, first filed Oct 29, 2025, last Mar 11, 2026. Henry L. Charlton, EVP & Chief Commercial and Mkt: sold $8.0M across 1 filing, first filed Nov 13, 2025, last Nov 13, 2025. Mark Brosius, SVP & Chief Mfg and Supply Cha → Officer (see filing) → EVP & Chief Mfg and Supply Cha: sold $3.5M across 15 filings, first filed Dec 15, 2025, last Sep 11, 2026. Iman Jeddi, SVP & GM da Vinci Platforms &: sold $2.4M across 1 filing, first filed Jun 2, 2026, last Jun 2, 2026. 6 others: sold $6.5M across 13 filings, first filed Oct 27, 2025, last Sep 16, 2026.
Largest mark · tap a row for others
Gary S. Guthart · Executive Chair of the Board o
Sale $17,299,192
31,600 shares at $547.44 avg
Filed Oct 27, 2025 · traded Oct 24
Pre-arranged (10b5-1) · close on filing date $551.25
Gary S. Guthart · Executive Chair of the Board o → Director
Executive Chair of the Board o → Director
$48.8M soldDavid J. Rosa · Chief Executive Officer (CEO)
Chief Executive Officer (CEO)
$13.4M soldMyriam Curet · EVP & Chief Medical Officer
EVP & Chief Medical Officer
$8.4M soldHenry L. Charlton · EVP & Chief Commercial and Mkt
EVP & Chief Commercial and Mkt
$8.0M soldMark Brosius · SVP & Chief Mfg and Supply Cha → Officer (see filing) → EVP & Chief Mfg and Supply Cha
SVP & Chief Mfg and Supply Cha → Officer (see filing) → EVP & Chief Mfg and Supply Cha
$3.5M soldIman Jeddi · SVP & GM da Vinci Platforms &
SVP & GM da Vinci Platforms &
$2.4M sold6 others
Combined, one mark per week
$6.5M soldHas Intuitive Surgical Inc.'s CEO sold stock?
Yes. David J. Rosa (CEO) sold 24,500 shares ($13.4M) in Oct 2025, all under a pre-arranged 10b5-1 plan.
Open-market trades
45 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Gary S. Guthart | Executive Chair of the Board o → Director | $48.8M | — | 4 | 100% of sales | |
| David J. Rosa | Chief Executive Officer (CEO) | $13.4M | — | 1 | 100% of sales | |
| Myriam Curet | EVP & Chief Medical Officer | $8.4M | — | 10 | 100% of sales | |
| Henry L. Charlton | EVP & Chief Commercial and Mkt | $8.0M | — | 1 | 100% of sales | |
| Mark Brosius | SVP & Chief Mfg and Supply Cha → Officer (see filing) → EVP & Chief Mfg and Supply Cha | $3.5M | — | 15 | 100% of sales | |
| Iman Jeddi | SVP & GM da Vinci Platforms & | $2.4M | — | 1 | 100% of sales | |
| Brian Edward Miller | EVP & Chief Digital Officer | $2.0M | — | 1 | 100% of sales | |
| Fredrik Widman | VP Corporate Controller | $1.8M | — | 4 | 100% of sales | |
| Craig H. Barratt | Director | $1.6M | — | 2 | 100% of sales | |
| Gary Loeb | EVP & Chief Legal and Complian | $500.0K | — | 3 | 100% of sales | |
| Amy L. Ladd | Director | $471.8K | — | 2 | 100% of sales | |
| Patricia L. Wadors | SVP Chief Human Resources Offi | $109.9K | — | 1 | 100% of sales |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Fredrik Widman VP Corporate Controller | SalePre-arranged (10b5-1) | 1,089 | $374.44 | $407.8K | 1,026 | |
traded | Mark Brosius EVP & Chief Mfg and Supply Cha | SalePre-arranged (10b5-1) | 48 | $357.10 | $17.1K | 764 | |
traded | Mark Brosius EVP & Chief Mfg and Supply Cha | SalePre-arranged (10b5-1) | 69 | $357.55 | $24.7K | 812 | |
traded | Mark Brosius EVP & Chief Mfg and Supply Cha | SalePre-arranged (10b5-1) | 154 | $385.97 | $59.4K | 881 | |
traded | Mark Brosius EVP & Chief Mfg and Supply Cha | SalePre-arranged (10b5-1) | 231 | $392.98 | $90.8K | 1,035 | |
traded | Gary S. Guthart Director | SalePre-arranged (10b5-1) | 10,000 | $400.00 | $4.0M | 1,245,679 | |
traded | Amy L. Ladd Director | SalePre-arranged (10b5-1) | 472 | $381.15 | $179.9K | 179 | |
traded | Gary Loeb EVP & Chief Legal and Complian | SalePre-arranged (10b5-1) | 400 | $379.00 | $151.6K | 5,320 | |
traded | Mark Brosius EVP & Chief Mfg and Supply Cha | SalePre-arranged (10b5-1) | 56 | $348.91 | $19.5K | 1,266 | |
traded | Mark Brosius EVP & Chief Mfg and Supply Cha | SalePre-arranged (10b5-1) | 84 | $356.60 | $30.0K | 1,322 | |
traded | Mark Brosius EVP & Chief Mfg and Supply Cha | SalePre-arranged (10b5-1) | 48 | $413.19 | $19.8K | 1,406 | |
traded | Gary Loeb EVP & Chief Legal and Complian | SalePre-arranged (10b5-1) | 400 | $424.14 | $169.7K | 5,720 | |
traded | Mark Brosius EVP & Chief Mfg and Supply Cha | SalePre-arranged (10b5-1) | 69 | $421.80 | $29.1K | 1,454 | |
traded | Iman Jeddi SVP & GM da Vinci Platforms & | SalePre-arranged (10b5-1) | 5,625 | $420.55 | $2.4M | 6,463 | |
traded | Mark Brosius EVP & Chief Mfg and Supply Cha | SalePre-arranged (10b5-1) | 36 | $442.92 | $15.9K | 1,523 | |
traded | Mark Brosius EVP & Chief Mfg and Supply Cha | SalePre-arranged (10b5-1) | 54 | $434.52 | $23.5K | 1,559 | |
traded | Gary Loeb EVP & Chief Legal and Complian | SalePre-arranged (10b5-1) | 400 | $446.95 | $178.8K | 6,120 | |
traded | Amy L. Ladd Director | SalePre-arranged (10b5-1) | 619 | $471.55 | $291.9K | 120 | |
traded | Myriam Curet EVP & Chief Medical Officer | SalePre-arranged (10b5-1) | 105 | $493.95 | $51.9K | 0 | |
traded | Mark Brosius SVP & Chief Mfg and Supply Cha | SalePre-arranged (10b5-1) | 1,293 | $487.61 | $630.5K | 1,613 | |
traded | Mark Brosius SVP & Chief Mfg and Supply Cha | SalePre-arranged (10b5-1) | 3,658 | $496.19 | $1.8M | 2,906 | |
traded | Myriam Curet EVP & Chief Medical Officer | SalePre-arranged (10b5-1) | 4,853 | $487.32 | $2.4M | 409 | |
traded | Fredrik Widman VP Corporate Controller | SalePre-arranged (10b5-1) | 367 | $495.68 | $181.9K | 1,026 | |
traded | Myriam Curet EVP & Chief Medical Officer | SalePre-arranged (10b5-1) | 2,345 | $499.71 | $1.2M | 409 | |
traded | Patricia L. Wadors SVP Chief Human Resources Offi | SalePre-arranged (10b5-1) | 220 | $499.71 | $109.9K | 0 | |
traded | Myriam Curet EVP & Chief Medical Officer | SalePre-arranged (10b5-1) | 526 | $494.90 | $260.3K | 409 | |
traded | Fredrik Widman VP Corporate Controller | SalePre-arranged (10b5-1) | 133 | $494.96 | $65.8K | 660 | |
traded | Myriam Curet EVP & Chief Medical Officer | SalePre-arranged (10b5-1) | 126 | $520.02 | $65.5K | 0 | |
traded | Gary S. Guthart Director | SalePre-arranged (10b5-1) | 27,300 | $530.24 | $14.5M | Multiple accounts | |
traded | Myriam Curet EVP & Chief Medical Officer | SalePre-arranged (10b5-1) | 230 | $532.61 | $122.5K | 0 | |
traded | Mark Brosius Officer (see filing) | SalePre-arranged (10b5-1) | 312 | $547.36 | $170.8K | 595 | |
traded | Mark Brosius Officer (see filing) | SalePre-arranged (10b5-1) | 464 | $548.49 | $254.5K | 131 | |
traded | Mark Brosius SVP & Chief Mfg and Supply Cha | SalePre-arranged (10b5-1) | 464 | $548.49 | $254.5K | 443 | |
traded | Myriam Curet EVP & Chief Medical Officer | SalePre-arranged (10b5-1) | 104 | $559.90 | $58.2K | 0 | |
traded | Gary S. Guthart Executive Chair of the Board o | SalePre-arranged (10b5-1) | 22,806 | $570.89 | $13.0M | 2,694 | |
traded | Myriam Curet EVP & Chief Medical Officer | SalePre-arranged (10b5-1) | 125 | $568.99 | $71.1K | 0 | |
traded | Craig H. Barratt Director | SalePre-arranged (10b5-1) | 750 | $580.00 | $435.0K | 0 | |
traded | Henry L. Charlton EVP & Chief Commercial and Mkt | SalePre-arranged (10b5-1) | 13,731 | $580.00 | $8.0M | 3,056 | |
traded | Myriam Curet EVP & Chief Medical Officer | SalePre-arranged (10b5-1) | 105 | $560.00 | $58.8K | 0 | |
traded | Brian Edward Miller EVP & Chief Digital Officer | SalePre-arranged (10b5-1) | 3,500 | $575.00 | $2.0M | 5,758 | |
traded | Fredrik Widman VP Corporate Controller | SalePre-arranged (10b5-1) | 2,067 | $550.00 | $1.1M | 473 | |
traded | Myriam Curet EVP & Chief Medical Officer | SalePre-arranged (10b5-1) | 7,687 | $548.34 | $4.2M | 0 | |
traded | Craig H. Barratt Director | SalePre-arranged (10b5-1) | 2,193 | $548.01 | $1.2M | 0 | |
traded | Gary S. Guthart Executive Chair of the Board o | SalePre-arranged (10b5-1) | 31,600 | $547.44 | $17.3M | Multiple accounts | |
traded | David J. Rosa Chief Executive Officer (CEO) | SalePre-arranged (10b5-1) | 24,500 | $547.55 | $13.4M | 234,256 |
GET /stocks/filings/vX/form-4?tickers=ISRG&filing_date.gte=2025-10-24&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"ISRG"
],
"issuer_cik": "0001035267",
"owner_cik": "0001897970",
"accession_number": "0001897970-26-000008",
"form_type": "4",
"filing_date": "2026-09-16",
"period_of_report": "2026-09-15",
"issuer_name": "INTUITIVE SURGICAL INC",
"issuer_trading_symbol": "ISRG",
"owner_name": "Widman Fredrik",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "VP Corporate Controller",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-09-15",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 543,
"transaction_price_per_share": 374.44,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 1026,
"transaction_value": 203320.92,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 15, 2027."
}
]
},
{
"tickers": [
"ISRG"
],
"issuer_cik": "0001035267",
"owner_cik": "0001897970",
"accession_number": "0001897970-26-000008",
"form_type": "4",
"filing_date": "2026-09-16",
"period_of_report": "2026-09-15",
"issuer_name": "INTUITIVE SURGICAL INC",
"issuer_trading_symbol": "ISRG",
"owner_name": "Widman Fredrik",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "VP Corporate Controller",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-09-15",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 546,
"transaction_price_per_share": 374.44,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 1026,
"transaction_value": 204444.24,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 15, 2027."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 141 records
- Option exercises89 records
- Tax withholding49 records
- Gifts2 records
- Other1 record
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
Build this yourself
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for ISRG every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Role
- The title on each filing. Someone whose title changed shows more than one.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- Counted once
- When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.